If you are interested in engaging in an innovative partnership with us to benefit you, Novo Nordisk and people with diabetes, obesity, haemophilia or adjacent diseases of high unmet need, including the delivery systems these patients rely on, please contact Vice Presidents Miriam Frieden and Uli Stilz and their dedicated teams at email@example.com.
We attend partnering events all over the world to meet with new potential partners. If you wish to arrange a meeting, please contact us.
|28-29 November 2017||BIOFIT||Strasbourg, France|
|4-6 January 2018||NASH-TAG CONFERENCE||Salt Lake City, Utah, USA|
|8-10 January 2018||BIOTECH SHOWCASE||San Francisco, CA, USA|
|1-3 March 2018||EASL HCC SUMMIT||Geneva, CH|
|12-14 March 2018||BIO-EUROPE SPRING||Amsterdam, NL|
|10-11 April 2018||DIABETES SUMMIT||Boston, MA, USA|
|23-25 April 2018||BIOTRINITY||London, UK|
|25-26 April 2018||CHINABIO PARTNERING FORUM||Suzhou, China|
|9-11 May 2018||BIO KOREA||Seoul, Korea|
|15-16 May 2018||BIOEQUITY EUROPE||Ghent, Belgium|
|4-7 June 2018||BIO 2018||Boston, MA, USA|
|22-26 June 2018||ADA||Orlando, FL, USA|
1. Identifying synergies
Our dedicated team of experts is constantly searching for well-suited collaborations where we can work with academia and biotech in strong partnerships to build on synergistic capabilities.
2. Building relationships
We build partnerships in numerous ways, tailored to the partners involved. But no matter the framework, we believe that a strong relationship is the foundation for a fruitful collaboration that develops both our partners and ourselves.
3. Fostering collaboration
We have well-established methodologies for working with our partners based on a long history of fruitful collaborations with diversified partners and cultures leveraging individual core competences.
4. Driving impact
We believe that partnerships with a clear scope in areas of mutual interest create the foundation for successful outcomes to the benefit of everyone involved, and ultimately the patients we serve.